AI consultancy, training & agents for pharma

Practical AI for pharma marketing, built around regulated workflows.

From AI training and workflow audits to agent-assisted congress intelligence, localisation and content QA, Iguazu helps pharma teams move from experimenting with AI to using it safely, confidently and productively.

A neon digital illustration of a human brain with a glowing "AI" symbol in the center, representing artificial intelligence workflows and autonomous marketing agents in the pharmaceutical industry.

Why Iguazu?

From AI experimentation to agent-assisted workflows

AI is no longer simply a tool for generating ideas or speeding up first drafts. For pharma teams, the real opportunity is using AI to reduce repetitive effort, retain organisational knowledge and support better decision-making across approved, human-reviewed workflows.

Iguazu has spent the last four years learning where AI genuinely helps pharma marketing teams – and where it needs structure, governance and expert review.

Four years of AI learning, testing and implementation

2022–2023

Exploration

Research into AI tools across content, design, development, PM, QA and pharma marketing.

2023–2024

Noxivision

A fictional pharma product used to test AI-assisted brand, campaign and content workflows.

2024–2025

Adoption

AI moved into briefing, localisation, content structure, artwork support and workshops.

2025–2026

AI Agents

Agent-assisted workflows for congress intelligence, localisation QA and Veeva readiness.

How we help pharma teams use AI

The strongest AI-use cases are not generic. They are specific, workflow-led and grounded in approved source materials, brand needs and sensible human review.

AI consultancy and workflow audits

We review workflows, source materials, approval processes and pain points to identify realistic AI opportunities.

Agent-assisted pharma workflows

Focused agents designed around specific processes, grounded in source materials and supported by human review.

AI training for pharma teams

Practical sessions covering prompt writing, safe AI use, content review, localisation, congress planning and governance.

Veeva AI readiness and configuration

Support to understand Veeva AI capabilities, prepare source materials, define governance and configure useful workflows.

Practical AI agents for pharma teams

AI agents should not be uncontrolled black boxes. In pharma, they need clear use cases, defined source materials, review points and practical governance.

Congress Intelligence & Workflow

Pre-congress packs, session triage, competitor activity, KOL mapping and post-congress insight memory.

Launch Readiness & Localisation

Market adaptation, localisation QA, asset readiness, claims consistency and launch preparation.

Competitor Monitoring

Monitor competitor websites, education content, campaign structures, SEO and AI search visibility.

Content Review & QA

Check broken links, missing references, brand consistency, accessibility and approval-readiness.

Veeva AI Configuration

Help clients make better use of emerging Veeva AI capabilities alongside partner-led workflow support.

Built for pharma workflows, including Veeva

Many pharma teams are already working inside Veeva ecosystems, and Veeva’s AI roadmap is changing how content may be checked, reused and governed.

Iguazu’s role is not to turn the whole AI story into a Veeva story. It is to make sure pharma content and workflows are structured, compliant and practical enough to work well across the systems clients already use – including CLM, Approved Email, PromoMats and future AI-assisted review processes.

Veeva content partner certification badge

Why Iguazu?

What AI-supported workflows can deliver

For brand teams

For medical & compliance

For commercial teams

Noxivision: our AI sandbox methodology

Noxivision was created as a fictional pharmaceutical product to test AI-assisted marketing in a controlled environment. It allowed Iguazu to explore how AI could support product positioning, brand identity, imagery, campaign development, MOA concepts and website content without using a live client brand.

Two people with glasses smiling, one looking up. Noxivision logo in the bottom right
The Future of Approved Emails in an AI-Driven Omnichannel World
Discover how AI is transforming pharmaceutical Approved Emails through smarter content creation, personalisation, localisation, journey orchestration and analytics.
A female scientist in a lab setting holding a tablet next to an EU AI Act Article 50 clipboard outlining transparency obligations and AI content disclosure for pharmaceutical companies.
EU AI Act Article 50 Is Live: What Pharma Teams Actually Need to Do
Four practical pharma AI scenarios showing when Article 50 may require disclosure or marking, where human review matters, and what teams should do now.
What our clients have to say:

"A really enjoyable and practical session, full of fantastic tips. I’m already using what I learned, and the advice around being specific with prompts is already making a difference."

— Pharma Brand Manager, after a company AI training session delivered by Iguazu

Frequently asked questions about AI consultancy, training and agents.

No. AI can assist with preparation, organisation, checking and analysis, but formal review and approval must remain with authorised people. Every workflow should define its sources, permissions, outputs and human review points.

Yes. Focused assistants can be grounded in approved claims, brand guidance, training content, congress outputs and other controlled sources. Suitability depends on the use case, permissions, data sensitivity and governance requirements.

Ask Iguazu about your pharma AI agent requirements

A governed workflow has a defined purpose, controlled sources, clear users, permissions, review stages and expected outputs. This reduces uncontrolled experimentation and makes the process easier to evaluate, document and improve.

Yes. Iguazu can help teams structure content and processes around existing Veeva workflows, including CLM, Approved Email, PromoMats and emerging AI capabilities. The aim is to complement existing systems.

Find out about Iguazu’s Veeva expertise

Choose a focused, repeatable task with clear inputs and a named reviewer – for example, congress briefing preparation, localisation comparison or a structured content QA check. Avoid starting with an autonomous, high-risk decision.

The scope can cover current tasks, users, content sources, tools, approval points, risks, data considerations and measurable effort. Iguazu then prioritises opportunities and recommends a manageable next step.

Ready to move from AI experimentation to practical pharma workflows?

Whether you need AI training, a workflow audit, a congress intelligence pilot, Veeva AI readiness support or a managed AI-supported service, Iguazu can help you identify the right starting point and build it safely.

AI often works best as part of a broader omnichannel programme

Website design and build

From website design, build and launch, we offer search engine optimisation and Google Analytics support on multiple platforms.

Approved emails

Send personalised, approved content for increased engagement with customers.

eDetail presentations

As interactive detailing experts, we help improve customer engagement with every tap.